KOD News and Press, Kodiak Sciences Inc From 03/30/19

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. China's Vice Premier Liu plans to travel to the U.S. next week in what could be ano...

Kodiak Sciences (NASDAQ: KOD ): Q4 GAAP EPS of -$0.40  misses by $0.09 . More news on: Kodiak Sciences Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

PALO ALTO, Calif. , March 28, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, reported business highlights and financial results for the fourth q...

PALO ALTO, Calif. , March 7, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that management will present at the Barclays Global ...

OrthoPediatrics (NASDAQ: KIDS ) initiated with Outperform rating and $44 (17% upside) price target at JMP Securities. More news on: OrthoPediatrics Corp., Homology Medicines, Kodiak Sciences, Healthcare stocks news, Stocks on the move, , Read more ...

PALO ALTO, Calif. , Feb. 8, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that a presentation on its investigational therapy KS...